Alaska Blind Child Discovery
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Alaska Blind Child Discovery sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Alaska Blind Child Discovery: 7 sponsored US clinical trials, 1 recruiting.
Alaska Blind Child Discovery sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Strabismus, with 1 trials.
Upper-quartile sponsor footprint
Alaska Blind Child Discovery sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
The Alaska Oculocardiac Reflex Study
NCT04353960
Refractive Accuracy of "2WIN" and Portable Autorefractors
NCT04249505
Comparative Validation of "Blinq" and "2WIN" Vision Screeners
NCT04195711
Hyperopia Detection GCK With Glow Fixation
NCT04297969
Enhanced Housing Photoscreeners 2WIN and GoCheckKids Compared in Burma and Alaska
NCT04068129
Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines
NCT03668067
ROP Check Database Premature Infant Outcomes
NCT07312669
Therapeutic Areas
What is open in the Alaska Blind Child Discovery pipeline
1 recruiting of 7 indexed (14% open); 6 completed (86%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Strabismus (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alaska Blind Child Discovery: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Alaska Blind Child Discovery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- American College of Radiology · 14% recruiting · 14 trials
Related
What to do with this Alaska Blind Child Discovery page
7 registered trials is a research-attention snapshot, not an endorsement of Alaska Blind Child Discovery or any single study.
- 1 of Alaska Blind Child Discovery's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Strabismus is the condition Alaska Blind Child Discovery studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Strabismus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Alaska Blind Child Discovery pipeline card: 7 registered trials from official public datasets.Report a data error.